Taylor Devices director sells 4,120 shares
Taylor Devices director F. Eric Armenat reported selling his remaining common shares of the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Taylor Devices director F. Eric Armenat reported selling his remaining common shares of the company. The Form 4 shows open-market sales on January 14, 2026 totaling 4,120 shares of Taylor Devices, Inc. common stock.
The first transaction was a sale of 3,820 shares at a weighted average price of $73.21 per share, with individual trade prices ranging from $72.65 to $73.57. A second sale of 300 shares at $74.00 per share is also reported. Following these transactions, Armenat reports 0 shares of Taylor Devices common stock held with direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,820 | $73.21 | $280K |
| Sale | Common Stock | 300 | $74.00 | $22K |
Footnotes (1)
- F1. The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.65 to $73.57. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What sale prices were reported in the TAYD Form 4?
What is F. Eric Armenat’s role at Taylor Devices (TAYD)?
Were the Taylor Devices (TAYD) sales executed as multiple trades?
Is there any indication of indirect ownership in this TAYD Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.